Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis

BACKGROUND: Testosterone is the standard treatment for male hypogonadism, but there is uncertainty about its cardiovascular safety due to inconsistent findings. We aimed to provide the most extensive individual participant dataset (IPD) of testosterone trials available, to analyse subtypes of all ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Hudson, Jemma, Cruickshank, Moira, Quinton, Richard, Aucott, Lorna, Aceves-Martins, Magaly, Gillies, Katie, Bhasin, Shalender, Snyder, Peter J, Ellenberg, Susan S, Grossmann, Mathis, Travison, Thomas G, Gianatti, Emily J, van der Schouw, Yvonne T, Emmelot-Vonk, Marielle H, Giltay, Erik J, Hackett, Geoff, Ramachandran, Sudarshan, Svartberg, Johan, Hildreth, Kerry L, Groti Antonic, Kristina, Brock, Gerald B, Tenover, J Lisa, Tan, Hui Meng, Kong, Christopher Ho Chee, Tan, Wei Shen, Marks, Leonard S, Ross, Richard J, Schwartz, Robert S, Manson, Paul, Roberts, Stephen, Andersen, Marianne Skovsager, Magnussen, Line Velling, Hernández, Rodolfo, Oliver, Nick, Wu, Frederick, Dhillo, Waljit S, Bhattacharya, Siladitya, Brazzelli, Miriam, Jayasena, Channa N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184259/
https://www.ncbi.nlm.nih.gov/pubmed/35711614
http://dx.doi.org/10.1016/S2666-7568(22)00096-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184259/
https://www.ncbi.nlm.nih.gov/pubmed/35711614
http://dx.doi.org/10.1016/S2666-7568(22)00096-4

Ejemplares similares